Rosetta Green

NEW YORK (GenomeWeb) – Roughly two years after it agreed to pay $518 million for Devgen and its portfolio of agricultural RNAi technologies, Syngenta announced this month that it is collaborating with Australian startup Nexgen to develop virus-resistant crop plants through microRNA targeting.

Just days after the acquisition of agricultural microRNA firm Rosetta Green by Monsanto was cleared by Israeli antitrust authorities, Rosetta Green’s former parent from Rosetta Genomics has opposed the deal.

Rosetta Green said this week that it has signed an agreement under which it licensed an undisclosed microRNA from Iowa State University for use in developing plants resistant to nematodes.
Specific terms of the deal were not disclosed.

Rosetta Green announced last week that it has struck a research collaboration with German plant breeding firm KWS to discover microRNAs that can improve sugar beet.

Rosetta Green last week announced that it has successfully completed an experiment producing biologically active human growth hormone from algae.

By Doug Macron

Rosetta Green announced this week that it is negotiating a deal under which “one of the world's largest seed companies” would license a “limited” number of microRNAs identified by Rosetta Green as potentially improving key traits within an undisclosed crop plant.

Rosetta Green announced this week that it has successfully altered tobacco plants, which serve as models for corn and soybean plants, to use seawater irrigation.

By Doug Macron
Rosetta Green this week announced that it has inked a strategic research deal with DuPont, its biggest partner to date, to identify microRNAs associated with drought tolerance in corn and soybeans.